Stengone Carmine N.
SEC insider (Form 3/4/5 filer). CIK 0001861519. CEO and President at Contineum Therapeutics, Inc. (CTNM) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in SAN DIEGO, CA.
Companies Stengone Carmine N. has filed insider reports for
- Contineum Therapeutics, Inc. (CTNM): Director, Officer, CEO and President
- KIORA PHARMACEUTICALS INC (KPRX): Director
Stengone Carmine N.
CIK: 0001861519
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Sep 8, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect2.5K shares at avg. $16.46$41K - Sep 8, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $1.01$3K - Aug 3, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect2.5K shares at avg. $16.01$40K - Aug 3, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $1.01$3K - Jul 8, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect2.5K shares at avg. $16.00$40K - Jul 8, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $1.01$3K - Jun 30, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect2.5K shares at avg. $1.26$3K - Jun 30, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $1.01$8K - Jun 30, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect10K shares at avg. $16.01$160K - Jun 10, 2026KPRX
KIORA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 |  CTNM Contineum Therapeutics, Inc. | Sale | 2,500 | $16.46 | $41,142 | Direct |
| Sep 8, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 2,500 | $1.01 | $2,525 | Direct |
| Aug 3, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 2,500 | $16.01 | $40,029 | Direct |
| Aug 3, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 2,500 | $1.01 | $2,525 | Direct |
| Jul 8, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 2,500 | $16.00 | $40,000 | Direct |
| Jul 8, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 2,500 | $1.01 | $2,525 | Direct |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 2,500 | $1.26 | $3,150 | Direct |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 7,500 | $1.01 | $7,575 | Direct |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 10,000 | $16.01 | $160,080 | Direct |
| Jun 10, 2026 |  KPRX KIORA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
1-10 of 20 transactions